U.S., April 1 -- ClinicalTrials.gov registry received information related to the study (NCT07502937) titled 'A Multicenter Interventional Study on the Use of a 3-Degree-of-Freedom (3DOF) Platform to E... Read More
U.S., April 1 -- ClinicalTrials.gov registry received information related to the study (NCT07504172) titled 'Real-world Effectiveness and Dosing Patterns of Tirzepatide in People With Obesity' on Marc... Read More
U.S., April 1 -- ClinicalTrials.gov registry received information related to the study (NCT07503886) titled 'An Exploratory Efficacy and Safety Study of DFL24498 Topical Ophthalmic Solution Compared W... Read More
U.S., April 1 -- ClinicalTrials.gov registry received information related to the study (NCT07503912) titled 'Evaluation of the Not A Number Trafficking Prevention Program in Minnesota' on March 06. B... Read More
U.S., April 1 -- ClinicalTrials.gov registry received information related to the study (NCT07502495) titled 'Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Who Are Not Achieving Glyc... Read More
U.S., April 1 -- ClinicalTrials.gov registry received information related to the study (NCT07503366) titled 'Standardized Italian netwoRk Enrolling iNdividuals With Islet-Autoantibodies' on March 25. ... Read More
U.S., April 1 -- ClinicalTrials.gov registry received information related to the study (NCT07504354) titled 'Comparative Study Between Using Combined Propofol Sedation With subTenon's Infusion as Loca... Read More
U.S., April 1 -- ClinicalTrials.gov registry received information related to the study (NCT07503704) titled 'A Prospective Study of the Genomic Landscape of Central Nervous System Disease Secondary to... Read More
U.S., April 1 -- ClinicalTrials.gov registry received information related to the study (NCT07503392) titled 'The Effect of Virtual Reality-Enhanced Teaching on Intravenous Catheter Insertion: A Random... Read More
U.S., April 1 -- ClinicalTrials.gov registry received information related to the study (NCT07502521) titled 'Dexrazoxane to Protect Against Hemorrhagic STEMI' on March 26. Brief Summary: This Phase I... Read More